Buoy Software

Buoy Software is on a mission to revolutionize the blood product donation industry, an area that has remained largely untouched by technological advancements for decades. The company recognized a critical need and a significant opportunity to leverage modern technology and thoughtful design to make a substantial impact. This endeavor is focused on three key areas: increasing the accessibility of blood product-derived biotherapies for patients with life-threatening conditions, generating employment opportunities and economic support in underserved communities, and delivering tangible business value by boosting the supply of blood products in a market experiencing escalating demand.

A core part of Buoy Software's strategy involves a close collaboration with its sister company, Join Parachute. Together, they are establishing small-market donation centers across the United States. These centers are designed not only to facilitate the collection of blood products but also to create local jobs and provide financial compensation for donations, thereby fostering positive economic impacts within these communities. The demand for blood products is growing at a rapid pace, and Buoy Software aims to bridge the gap between this increasing demand and the current supply by equipping organizations with innovative and effective tools. The company's flagship product is an intuitive, data-driven mobile application designed for donors, streamlining the donation process and enhancing the overall experience. In an industry that has seen little innovation for over twenty years, Buoy's software is engineered to create a seamless donation journey, with user-friendly navigation for both donors and facilitators, and to motivate donors to schedule future appointments. This, in turn, is expected to increase plasma donations, addressing a multi-year shortage and enabling the continued evolution and life-saving potential of plasma-derived biotherapies for conditions such as immune deficiencies and blood disorders. Buoy Software is committed to playing a pivotal role in improving the state of blood products and donations, recognizing the worldwide health implications of inaction.